Ratings by Goldman Sachs (Madhu Kumar)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/1/2022 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2022 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2022 | Magenta Therapeutics | MGTA | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2022 | Edgewise Therapeutics | EWTX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/10/2022 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2022 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Neutral (N/A) |
|
Details | ||
| 5/5/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2022 | Tricida | TCDA | New Coverage | Buy (N/A) |
9.64 (9.64) |
0% | Details | |
| 4/13/2022 | Alector Inc. | ALEC | New Coverage | Sell (N/A) |
12.28 (11.02) |
-10.26% | Details | |
| 4/6/2022 | Jazz Pharmaceuticals | JAZZ | Downgrade | Neutral (Buy) |
160.73 (158.58) |
-1.34% | Details | |
| 3/24/2022 | Reata Pharmaceuticals | RETA | New Coverage | Buy (N/A) |
37.09 (30.44) |
-17.93% | Details | |
| 3/15/2022 | Design Therapeutics Inc | DSGN | Maintain | Sell (N/A) |
|
Details | ||
| 3/8/2022 | Magenta Therapeutics | MGTA | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2022 | Passage Bio Inc. | PASG | Maintain | Neutral (N/A) |
|
Details | ||
| 3/2/2022 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Cerevel Therapeutics | CERE | Maintain | (Neutral) |
|
Details | ||
| 3/1/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Arcturus Therapeutics | ARCT | Maintain | Sell (N/A) |
|
Details | ||
| 3/1/2022 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2022 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2022 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2022 | Editas Medicine | EDIT | Maintain | Sell (N/A) |
|
Details | ||
| 2/15/2022 | Cerevel Therapeutics | CERE | New Coverage | Neutral (N/A) |
30.63 (26.42) |
-13.74% | Details | |
| 2/15/2022 | Syndax Pharmaceuticals | SNDX | New Coverage | Buy (N/A) |
14.98 (19.07) |
27.3% | Details | |
| 1/28/2022 | Edgewise Therapeutics | EWTX | New Coverage | Neutral (N/A) |
14.00 (8.08) |
-42.29% | Details | |
| 1/28/2022 | Cytokinetics | CYTK | New Coverage | Buy (N/A) |
30.24 (41.00) |
35.58% | Details | |
| 1/19/2022 | Arrowhead Pharma | ARWR | New Coverage | Buy (N/A) |
57.81 (35.96) |
-37.8% | Details | |
| 1/19/2022 | Passage Bio Inc. | PASG | New Coverage | Neutral (N/A) |
5.76 (2.38) |
-58.68% | Details | |
| 1/19/2022 | TCR2 Therapeutics | TCRR | New Coverage | Neutral (N/A) |
4.01 (2.89) |
-27.93% | Details | |
| 1/19/2022 | Design Therapeutics Inc | DSGN | New Coverage | Sell (N/A) |
15.85 (14.09) |
-11.1% | Details | |
| 1/19/2022 | Arvinas Inc. | ARVN | New Coverage | Buy (N/A) |
67.42 (42.58) |
-36.84% | Details | |
| 1/6/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2022 | Dynavax Technologies | DVAX | New Coverage | Buy (N/A) |
13.40 (12.96) |
-3.28% | Details | |
| 1/6/2022 | Magenta Therapeutics | MGTA | Upgrade | Buy (Neutral) |
4.77 (1.31) |
-72.54% | Details | |
| 11/29/2021 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2021 | Jazz Pharmaceuticals | JAZZ | New Coverage | Buy (N/A) |
133.09 (158.58) |
19.15% | Details | |
| 11/19/2021 | Horizon Therapeutics | HZNP | Upgrade | Buy (Neutral) |
108.08 (80.84) |
-25.2% | Details | |
| 11/12/2021 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2021 | Dicerna Pharmaceuticals | DRNA | Maintain | Neutral (N/A) |
|
Details | ||
| 11/9/2021 | Arcturus Therapeutics | ARCT | Maintain | Sell (N/A) |
|
Details | ||
| 11/5/2021 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2021 | Myovant Sciences Ltd. | MYOV | Maintain | Neutral (N/A) |
|
Details | ||
| 9/13/2021 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2021 | Applied Therapeutics | APLT | Downgrade | Sell (Neutral) |
17.44 (0.87) |
-95.01% | Details | |
| 8/20/2021 | Myovant Sciences Ltd. | MYOV | New Coverage | Neutral (N/A) |
20.97 (12.96) |
-38.2% | Details | |
| 8/20/2021 | Magenta Therapeutics | MGTA | New Coverage | Neutral (N/A) |
6.16 (4.77) |
-22.56% | Details | |
| 8/11/2021 | Dicerna Pharmaceuticals | DRNA | Downgrade | Neutral (Buy) |
23.83 (38.22) |
60.39% | Details | |
| 8/11/2021 | Arcturus Therapeutics | ARCT | Downgrade | Sell (Neutral) |
48.24 (16.16) |
-66.5% | Details | |
| 8/10/2021 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2021 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2021 | Dynavax Technologies | DVAX | New Coverage | Buy (N/A) |
9.88 (13.40) |
35.63% | Details | |
| 7/20/2021 | Krystal Biotech | KRYS | Upgrade | Buy (Neutral) |
61.09 (67.47) |
10.44% | Details | |
| 6/25/2021 | Arcturus Therapeutics | ARCT | New Coverage | Neutral (N/A) |
34.03 (16.16) |
-52.51% | Details | |
| 6/25/2021 | Applied Therapeutics | APLT | New Coverage | Neutral (N/A) |
25.04 (17.44) |
-30.35% | Details | |
| 5/21/2021 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2021 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (Buy) |
|
Details | ||
| 5/17/2021 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2021 | Editas Medicine | EDIT | Maintain | Sell (N/A) |
|
Details | ||
| 5/10/2021 | Krystal Biotech | KRYS | Maintain | Neutral (N/A) |
|
Details | ||
| 4/16/2021 | Editas Medicine | EDIT | New Coverage | Sell (N/A) |
41.53 (12.59) |
-69.68% | Details | |
| 4/16/2021 | Iovanace Biotherapeutics | IOVA | New Coverage | Buy (N/A) |
29.99 (11.47) |
-61.75% | Details | |
| 4/16/2021 | Dicerna Pharmaceuticals | DRNA | New Coverage | Buy (N/A) |
27.83 (38.22) |
37.33% | Details | |
| 4/16/2021 | Apellis Pharmaceuticals | APLS | New Coverage | Buy (N/A) |
44.48 (45.43) |
2.14% | Details |
